Reportlinker Adds Intravenous (IV) Therapy and Vein Access: Global Markets
NEW YORK, Sept. 23 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Intravenous (IV) Therapy and Vein Access: Global Markets
http://www.reportlinker.com/p0297995/Intravenous-IV-Therapy-and-Vein-Access-Global-Markets.html
In 2009, the total global intravenous therapy and vein access market reached nearly $8.8 billion and is forecast to reach $11.2 billion in 2014, a compound annual growth rate (CAGR) of 5%.
Insulin-infusion pumps are expected to show the greatest demand over the forecast period. This segment was worth $1.1 billion in 2009 and is expected to increase at an 8.1% compound annual growth rate (CAGR) to reach $1.6 billion in 2014.
The central venous access devices and implantable pumps segment will experience a 5.7% compound annual growth rate (CAGR) over the forecast period. This market was valued at $975 million in 2009 and is expected to reach a value of nearly $1.3 billion in 2014.
INTRODUCTION
STUDY GOALS AND OBJECTIVES
The objectives of the study are to present a comprehensive look at the intravenous (IV) therapy device and vein access market. There are eight general categories of IV therapy:
Ambulatory infusion pumps
Central venous access devices
Diabetes insulin-infusion pump
Enteral feeding pump and tubes
Implantable pumps
Large-volume infusion pumps
Peripheral venous access devices
Syringe infusion pumps
REASONS FOR STUDY
This BCC study is presented to increase the awareness of IV therapy devices and vein access. The study analyzes the IV therapy market from different standpoints and addresses issues and trends affecting IV therapy administration. IV therapy and vein access device manufacturers, driven by both research breakthroughs and increased recognition of expanding market opportunities, have stepped up the pace of development of innovative devices. Because of the evolving nature of this important area of medicine, executives of IV therapy devices must remain ever vigilant of the changing environment and strive to keep abreast of new and currently used modalities in all facets of IV therapy.
SCOPE OF STUDY
This report is a comprehensive business tool designed to provide an in-depth look at the market for IV therapy and vein access. The geographic scope of the report is the global. The report describes the industry, its relationship to the healthcare industry and its participants, and trends for the future.
Categories discussed in the report include:
Ambulatory infusion pumps
Central venous access devices
Diabetes insulin-infusion pump
Enteral feeding pump and tubes
Implantable pumps
Large-volume infusion pumps
Peripheral venous access devices
Syringe infusion pumps.
All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2009 to 2014, and assessing the competitors and competitor market shares.
METHODOLOGY AND INFORMATION SOURCES
The information and analysis presented in this BCC report are based on extensive firsthand interviews with primary executives, product managers, and clinical specialists in the intravenous infusion and vein access arena. Background information was obtained from various government agencies, business and medical journals, trade magazines, and interviews with doctors and nurses involved in the administration of intravenous therapy and vein access.
Key information from published literature was used to conduct interviews with over 22 industry participants to validate and obtain expert opinions on current and future trends in the IV therapy and vein access industry. Interviews were the primary basis for development of market size. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as formulating market projections.
All market data pertain to the global market at the manufacturer's level. Data are expressed in current U.S. dollars. The base year was 2009. Historical data are provided for 2008 and forecast data are provided for 2014. Historical, base year, and forecast data are provided for each market segment and subsegment. Market shares are provided for each market segment for the 2009 base year.
ANALYST CREDENTIALS
Mary Anne Crandall is an expert industry analyst specializing in the pharmaceutical industry for the last 18 years. She has completed several in-depth studies on various medical topics requiring both medical expertise and excellent knowledge of the pharmaceutical industry. Ms. Crandall has extensive knowledge in the medical field, has a MS in psychology, and is currently working on a PhD.
Chapter- 1: INTRODUCTION -- Complimentary
CHAPTER ONE: INTRODUCTION 1
STUDY GOALS AND OBJECTIVES 1
REASONS FOR STUDY 1
SCOPE OF STUDY 1
METHODOLOGY AND INFORMATION SOURCES 2
ANALYST CREDENTIALS 2
RELATED BCC REPORTS 3
BCC ONLINE SERVICES 3
DISCLAIMER 4
Chapter-2: EXECUTIVE SUMMARY
CHAPTER TWO: EXECUTIVE SUMMARY 5
EXECUTIVE SUMMARY (CONTINUED) (CONTINUED) 6
SUMMARY TABLE GLOBAL MARKET FORECAST FOR IV THERAPY
DEVICE AND VEIN ACCESS MARKETS, THROUGH 2014
($ MILLIONS) 7
SUMMARY FIGURE GLOBAL MARKET FORECAST IV THERAPY DEVICE AND VEIN ACCESS MARKETS, 2009 AND 2014 ($ MILLIONS) 7
Chapter-3: INDUSTRY OVERVIEW
CHAPTER THREE: INDUSTRY OVERVIEW 8
HISTORICAL DEVELOPMENT OF TRANSFUSION THERAPY 8
BACKGROUND TO INFUSION THERAPY 8
FUNCTIONS OF THE CIRCULATORY SYSTEM 9
CIRCULATORY SYSTEM 10
GENERAL PRINCIPLES OF IV THERAPY 10
TYPES OF IV ADMINISTRATION 11
Continuous Intravenous Drip 11
Bolus 11
Intravenous Push 11
Titration 11
INFUSION PUMPS 12
INFUSION RATE 12
INFUSION RATE (CONTINUED) 13
FREE FLOW 14
START-UP TIME 15
GENERAL FEATURES AND SAFEGUARDS 15
RISK MANAGEMENT 16
SOPHISTICATION OF INFUSION PUMPS 17
OCCLUSIONS 17
OCCLUSIONS (CONTINUED) 18
CHARACTERISTICS, LIMITATIONS, AND CONFIGURATION OF INFUSION DEVICES 19
SAFETY ISSUES 20
SAFETY ISSUES (CONTINUED) 21
SAFETY ISSUES (CONTINUED) 22
PATIENT COMFORT 23
PATIENT COMFORT (CONTINUED) 24
NEW MATERIALS AND SIMPLER DESIGNS 25
INSURANCE REIMBURSEMENT ISSUES 26
INSURANCE REIMBURSEMENT ISSUES (CONTINUED) 27
2010 CODING AND REIMBURSEMENT GUIDE 28
INNOVATIVE TREATMENT OPTIONS 29
TUBELESS PUMPS 30
INFUSION DELIVERY PRESSURE 31
HOSPITAL INFUSION 32
IMPACT OF HOME INFUSION THERAPY 32
TABLE 1 TYPES OF HOME CARE/ALTERNATIVE SITES 33
KEY FACTORS FUELING THE GROWTH IN HOME CARE 34
Demographics 34
TABLE 2 U.S. OLDER POPULATION BY AGE GROUP 34
TABLE 2 (CONTINUED) 35
TABLE 3 GLOBAL POPULATION BY SELECTED GEOGRAPHICAL
REGION, 2008-5050 ($ MILLIONS) 35
FIGURE 1 GLOBAL POPULATION BY SELECTED GEOGRAPHICAL REGION, 2008–2050 (MILLIONS) 36
Technology 36
Managed Care 37
HOME/ALTERNATE SITE INFUSION PROVIDERS 37
Regulation 38
Provider Trends 38
PHARMACEUTICAL SPECIALTY DELIVERY 39
GROWTH POTENTIAL 40
MEDICARE PART D 40
IV THERAPY EDUCATION 41
HOME TELEINFUSION 41
HOME TELEINFUSION (CONTINUED) 42
HOME TELEINFUSION (CONTINUED) 43
HOME TELEINFUSION (CONTINUED) 44
USER-DRIVEN INNOVATIONS 45
INFUSION PUMP PROBLEMS AND RECALLS 46
INFUSION PUMP PROBLEMS AND RECALLS (CONTINUED) 47
INFUSION PUMP PROBLEMS AND RECALLS (CONTINUED) 48
VERTICAL INTEGRATION ISSUES 49
GENERIC PARTICIPATION 49
SURGERY AND INFUSION THERAPY 50
TABLE 4 INPATIENT PROCEDURES, 2007 (THOUSANDS) 50
TABLE 4 (CONTINUED) 51
FIGURE 2 INPATIENT PROCEDURES, 2007 (THOUSANDS) 51
SKILLED NURSING FACILITIES AND INFUSION THERAPY 52
TABLE 5 SKILLED NURSING FACILITIES AND BEDS, 2005 AND 2007 52
DEMOGRAPHICS 52
TABLE 6 U.S. DEMOGRAPHICS BY SEX AND AGE, 2008-2015
(MILLIONS) 52
TABLE 6 (CONTINUED) 53
FIGURE 3 U.S. DEMOGRAPHICS BY SEX AND AGE, 2008-2015 (MILLIONS) 53
DISTRIBUTION OF INTRAVENOUS THERAPY EQUIPMENT 53
AMBULATORY INFUSION PUMPS 54
SELECT PRODUCTS 55
Ipump Infusion Pump 55
CADD Infusion Pumps 55
WalkMed IC Infusion Pump 56
GemStar Infusion Pump 56
Alaris Gemini PC1 Infusion Pump 56
2000 Plus Infusion Pump 56
Paragon and Vivus 4000 Infusion Pumps 57
VIP and Sidekick Infusion Pump 57
ambIT Patient-Controlled Analgesia (PCA) Infusion Pump 57
Eureka-IPTM Infusion Pump 58
Delphi IVantage Infusion Pump 58
TABLE 7 SELECTED AMBULATORY INFUSION PUMPS AND
MANUFACTURERS 58
TABLE 7 (CONTINUED) 59
MARKET AND COMPETITIVE DATA 59
TABLE 8 GLOBAL MARKET FORECAST FOR AMBULATORY INFUSION
PUMPS, THROUGH 2014 ($ MILLIONS) 60
FIGURE 4 GLOBAL MARKET FORECAST FOR AMBULATORY INFUSION PUMPS, 2009 AND 2014 ($ MILLIONS) 60
TABLE 9 MANUFACTURERS' MARKET SHARE OF
AMBULATORY INFUSION PUMPS, 2009 (%) 61
FIGURE 5 MANUFACTURERS' MARKET SHARE OF AMBULATORY INFUSION PUMPS, 2009 (%) 61
CENTRAL VENOUS ACCESS DEVICES 61
CENTRAL VENOUS ACCESS DEVICES (CONTINUED) 62
CENTRAL VENOUS ACCESS DEVICES (CONTINUED) 63
RISKS 64
PRODUCTS 65
Arrow Multi-Lumen Access Catheter 65
Hickman, Leonard, Broviac, and Groshong Catheters 65
Cook Catheter 66
Circle C Chronic and Acute Hemodialysis Catheters 66
NeoStar 66
LifePort and Infuse-A-Port System 66
Dignity, HemoCath LT 67
Vantex Catheter 67
TABLE 10 SELECTED CENTRAL VENOUS ACCESS DEVICES
AND MANUFACTURERS 68
MARKET AND COMPETITIVE DATA 68
TABLE 11 GLOBAL MARKET FORECAST FOR CENTRALVENOUS
ACCESSES, THROUGH 2014 ($ MILLIONS) 69
FIGURE 6 GLOBAL MARKET FORECAST FOR CENTRAL VENOUS ACCESSES, 2009 AND 2014 ($ MILLIONS) 69
TABLE 12 MANUFACTURERS' MARKET SHARE OF CENTRAL
VENOUS ACCESS, 2009 (%) 70
FIGURE 7 MANUFACTURERS' MARKET SHARE OF CENTRAL VENOUS ACCESS, 2009 (%) 70
DIABETES INSULIN-INFUSION PUMPS 70
DIABETES INSULIN-INFUSION PUMPS (CONTINUED) 71
DIABETES INSULIN-INFUSION PUMPS (CONTINUED) 72
PRODUCTS 73
MiniMed Paradigm 73
MIP 2001 Promedos ID3 73
Infusaid Model 1000 73
Infusaid Model 1000 (Continued) 74
ACCU-CHEK Spirit Insulin Pump 75
Animas Insulin Pumps 75
OmniPod Insulin Management System 76
DANA Diabecare II and Diabecare IISG 77
ADI Insulin Pump 77
Amigo Insulin Pump 77
TABLE 13 SELECTED INSULIN-INFUSION PUMPS AND
MANUFACTURERS 78
MARKET AND COMPETITIVE DATA 78
TABLE 14 GLOBAL MARKET FORECAST FOR DIABETES INSULIN
INFUSION PUMPS, THROUGH 2014 ($ MILLIONS) 79
FIGURE 8 GLOBAL MARKET FORECAST FOR DIABETES INSULIN-INFUSION PUMPS, 2009 AND 2014 ($ MILLIONS) 80
TABLE 15 MANUFACTURERS' MARKET SHARE OF DIABETES INSULIN
INFUSION PUMPS, 2009 (%) 80
FIGURE 9 MANUFACTURERS' MARKET SHARE OF DIABETES INSULIN-INFUSION PUMPS, 2009 (%) 81
ENTERAL FEEDING PUMPS AND TUBES 81
PRODUCTS 82
Flexiflo, Quantum, and Patrol Enteral Pumps 82
Kangaroo Enteral Pumps 83
Noa III 83
Zevex Enteral Pumps 83
ALASKA, Applix Smart, Miniflo, Pilot 84
Q Core EF34 84
Compat Enteral Pump 85
TABLE 16 SELECTED ENTERAL FEEDING PUMPS AND
MANUFACTURERS 85
MARKET AND COMPETITIVE DATA 85
TABLE 17 GLOBAL MARKET FORECAST FOR ENTERAL FEEDING
PUMPS AND TUBES, THROUGH 2014 ($ MILLIONS) 86
FIGURE 10 GLOBAL MARKET FORECAST FOR ENTERAL FEEDING PUMPS AND TUBES, 2009 AND 2014 ($ MILLIONS) 87
TABLE 19 MANUFACTURERS' MARKET SHARE OF ENTERAL FEEDING
PUMPS AND TUBES, 2009 (%) 87
FIGURE 11 MANUFACTURERS' MARKET SHARE OF ENTERAL FEEDING PUMPS AND TUBES, 2009 (%) 88
IMPLANTABLE INFUSION PUMPS 88
ACCESS PORTS 89
PULSATIVE PUMPS 90
VAPOR-PRESSURE-POWERED PUMPS 90
PERISTALTIC PUMPS 91
Peristaltic Pumps (Continued) 92
PRODUCTS 92
SynchroMed Infusion System 92
MARKET AND COMPETITIVE DATA 93
TABLE 19 GLOBAL MARKET FORECAST FOR IMPLANTABLE
INFUSION PUMPS, THROUGH 2014 94
FIGURE 12 GLOBAL MARKET FORECAST FOR IMPLANTABLE INFUSION PUMPS, 2009 AND 2014 ($ MILLIONS) 94
TABLE 20 MANUFACTURERS' MARKET SHARE OF
IMPLANTABLE INFUSION PUMPS, 2009 (%) 95
FIGURE 13 MANUFACTURERS' MARKET SHARE OF IMPLANTABLE INFUSION PUMPS, 2009 (%) 95
LARGE-VOLUME INFUSION PUMPS 95
PRODUCTS 96
COLLEAGUE Pump 96
FLO-GARD 6201 AND 6301 96
Hospira Plum A+/Plum A+3 Infusion Systems 96
Symbiq 97
Omni-Flow 4000 Plus 97
Horizon Nxt 97
Optima MS 97
MedSystem III 97
Z-800 98
Deltec 3000 and Deltec Micro 3100 98
TABLE 21 SELECTED LARGE-VOLUME PUMPS AND
MANUFACTURERS 98
MARKET AND COMPETITIVE DATA 98
TABLE 22 GLOBAL MARKET FORECAST FOR LARGE-VOLUME
INFUSION PUMPS, THROUGH 2014 ($ MILLIONS) 99
FIGURE 14 GLOBAL MARKET FORECAST FOR LARGE-VOLUME INFUSION PUMPS, 2009 AND 2014 ($ MILLIONS) 100
TABLE 23 MANUFACTURERS' MARKET SHARE OF LARGE
VOLUME INFUSION PUMPS, 2009 100
FIGURE 15 MANUFACTURERS' MARKET SHARE OF LARGE-VOLUME INFUSION PUMPS, 2009 (%) 101
PERIPHERAL VENOUS ACCESS DEVICES 101
PRODUCTS 102
Xcela and Vaxcel with PASV Valved Venous Access 102
V-Cath 102
Poly RadPICC, PowerPICC Solo, Power Groshong PICC, Poly Per-Q-Cath 102
Vygon Lifevac PICC and Nutriline Midline/Midclavicular Catheters 102
Argyle PICC 103
ProPICC CT 103
Morpheus CT PICC 103
BD First PICC Catheter and BD First Midcath Midline Catheter 103
TABLE 24 SELECTED PERIPHERAL VENOUS ACCESS DEVICES
AND MANUFACTURERS 104
MARKET AND COMPETITIVE DATA 104
TABLE 25 GLOBAL MARKET FORECAST FOR PERIPHERAL
VENOUS ACCESS DEVICES, THROUGH 2014 ($ MILLIONS) 105
FIGURE 16 GLOBAL MARKET FORECAST FOR THE PERIPHERAL VENOUS ACCESS DEVICES, 2009 AND 2014 ($ MILLIONS) 105
TABLE 26 MANUFACTURERS' MARKET SHARE OF PERIPHERAL
VENOUS ACCESS DEVICES, 2009 (%) 106
FIGURE 17 MANUFACTURERS' MARKET SHARE OF PERIPHERAL VENOUS ACCESS DEVICES, 2009 (%) 106
SYRINGE INFUSION PUMPS 106
PRODUCTS 107
Alaris Syringe Line 107
MicroFuse Syringe Pumps 107
AS50A Infusion Pump 107
NIKI 108
LifeCare PCA 108
Injectomat, Master, and Pilot 108
Excelsior Syringe Pump 108
Graseby Syringe Drivers 109
OutBound Disposable Syringe Infuser 109
Medfusion Line 109
FREEDOM60 Syringe Infusion System 110
TABLE 27 SELECTED SYRINGE PUMPS AND MANUFACTURERS 110
MARKET AND COMPETITIVE DATA 111
TABLE 28 GLOBAL MARKET FORECAST FOR SYRINGE INFUSION
PUMPS, THROUGH 2014 ($ MILLIONS) 111
FIGURE 18 GLOBAL MARKET FORECAST FOR SYRINGE INFUSION PUMPS, 2009 AND 2014 ($ MILLIONS) 112
TABLE 29 MANURACTURERS' MARKET SHARE OF SYRINGE
INFUSION PUMPS, 2009 (%) 112
FIGURE 19 MANUFACTURERS' MARKET SHARE OF SYRINGE INFUSION PUMPS, 2009 (%) 113
OTHER 113
OTHER (CONTINUED) 114
Chapter-4: TOTAL MARKET SIZE AND GROWTH
CHAPTER FOUR: TOTAL MARKET SIZE AND GROWTH 115
TABLE 30 GLOBAL MARKET FORECAST FOR IV THERAPY DEVICE
AND VEIN ACCESS, TROUGH 2014 ($ MILLIONS) 115
FIGURE 20 GLOBAL MARKET FORECAST FOR I.V. THERAPY DEVICE AND VEIN ACCESS MARKETS, 2009 AND 2014 ($ MILLIONS) 116
FIGURE 21 MARKET SIZE OF GLOBAL I. V. THERAPY DEVICE AND VEIN ACCESS MARKETS, 2009 (%) 117
RECENT DEVELOPMENTS 118
NANOPUMP 118
DISPOSABLE CSII 118
PATCH CSII 118
LIGHTY 118
SOLO MICROPUMP 119
EKPUMP 119
PDD INNOVATIONS 119
FLUIDNET 120
Chapter-5: TECHNOLOGY ANALYSIS
CHAPTER FIVE: TECHNOLOGY ANALYSIS 121
TABLE 31 U.S. PATENT INFORMATION BY DATE FOR
INFUSION/INTRAVENOUS PUMPS AND RELATED DEVICES 121
TABLE 31 (CONTINUED) 122
Chapter-6: MARKET ANALYSIS
CHAPTER SIX: MARKET ANALYSIS 123
MARKET ANALYSIS 123
MARKET ANALYSIS (CONTINUED) 124
Chapter-7: COMPETITIVE ANALYSIS
CHAPTER SEVEN: COMPETITIVE ANALYSIS 125
TABLE 32 IV THERAPY DEVICE AND VEIN ACCESS
MANUFACTURERS BY TYPE, 2009 125
TABLE 32 (CONTINUED) 126
Chapter-8: MARKET OUTLOOK
CHAPTER EIGHT: MARKET OUTLOOK 127
Chapter-9: COMPANY PROFILES
CHAPTER NINE: COMPANY PROFILES 128
JOHNSON & JOHNSON/ANIMAS CORPORATION 128
HISTORY 128
Revenue History 129
BAXTER INTERNATIONAL, INC. 129
HISTORY 129
Revenue History 129
B. BRAUN MELSUNGEN AG 130
HISTORY 130
Revenue History: 131
BECTON, DICKINSON AND COMPANY 131
HISTORY 131
Revenue History 132
CAREFUSION, INC. 132
HISTORY 133
Revenue History 133
COVIDIEN PLC 133
HISTORY 134
Revenue History: 134
FRESENIUS KABI, LTD. 134
HISTORY 134
Revenue History 135
HOSPIRA, INC. 135
HISTORY 135
Revenue History 135
I FLOW CORPORATION 136
HISTORY 136
Revenue History 137
INSULET CORPORATION 137
HISTORY 137
Revenue History 137
IRADIMED CORPORATION 138
HISTORY 138
Revenue History 138
MEDEX, INC. 138
HISTORY 139
Revenue History 139
MEDTRONIC, INC. 139
HISTORY 140
Revenue History 140
SMITHS MEDICAL 140
HISTORY 141
Revenue History 141
TELEFLEX, INC. 142
HISTORY 143
Revenue History: 143
ZEVEX, INC/MOOG 144
HISTORY 144
Revenue History 145
APPENDIX
To order this report:
Therapy Industry: Intravenous (IV) Therapy and Vein Access: Global Markets
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT: |
|
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article